Betahistine: Known uses and market status in India
Summary
The TxGNN deep-learning model has no candidate indication with a score of 0.99 or higher for Betahistine, so there is currently no new predicted indication. The drug’s own recorded uses are listed below. They are existing records, not model candidates.
Quick overview
Item
Content
New predicted indications
None (no model candidate scored 0.99 or higher)
Known uses recorded for this drug
2
Evidence level
Not applicable
India Market Status
Listed in a compiled Indian medicine price dataset (at least 20) – CDSCO approval status is not included in this data
Number of Listed Products
at least 20
Known uses recorded for this drug
Approved (supported by a licence or label)
Indication
Source
meniere disease
Licence in another country
Related to an approved indication (same disease category)
Indication
Approved category
none
none
Relations recorded in the knowledge graph (no approval found)
Indication
endolymphatic hydrops
India Market Information
Licence
Product
Dosage form
Status
62543
Dvert 16mg Tablet
strip of 10 tablets
Valid
27629
Betatine 8 Tablet
strip of 10 tablets
Valid
246608
Zevert 16 Tablet DT
strip of 10 tablet dt
Valid
31727
Bitasafe 8 Tablet
strip of 10 tablets
Valid
238299
Vergone 48mg Tablet SR
strip of 10 tablet sr
Valid
28794
Betavertin 16mg Tablet
strip of 10 tablets
Valid
239028
Verticod 8mg Tablet
strip of 10 tablets
Valid
237683
Vertibest 8 Tablet
strip of 10 tablets
Valid
97153
Gidinor 16mg Tablet
strip of 10 tablets
Valid
26551
Bvert OD 24mg Tablet CR
strip of 10 tablet cr
Valid
26228
B-Stil 16 Tablet
strip of 10 tablets
Valid
240383
Vertimore 8mg Tablet
strip of 10 tablets
Valid
31320
Betorist 24 mg Tablet
strip of 10 tablets
Valid
145120
Meneas 24mg Tablet
strip of 10 tablets
Valid
138792
Meniertin V 16mg Tablet
strip of 10 tablets
Valid
104584
Hestin B 16mg Tablet
strip of 10 tablets
Valid
207093
Spinstek 24mg Tablet
strip of 10 tablets
Valid
209597
Sivert 16mg Tablet
strip of 10 tablets
Valid
119538
Kcbist 8mg Tablet
strip of 10 tablets
Valid
104702
Hybet 24mg Tablet
strip of 10 tablets
Valid
Only part of the licence list is held in the data; the list may be incomplete.
Safety Considerations
Please refer to the package insert for safety information. No label warnings, contraindications or drug-interaction records were available in the compiled data. A 2015 Prescrire note (PMID 26688903) raised the possibility of hallucinations with betahistine; this has not been assessed further here.
Disclaimer
This content is for research purposes only and does not constitute medical advice.
Clinical validation is required before any clinical application.